Olivier Chiarisoli serves as President of the Supervisory Board at Eydo Pharma, since february 2011. He serves as an Angel Investor at Olivier Chiarisoli. Olivier graduated from the French veterinary school of Nantes. He started his career in the pharmaceutical industry where he was successively in charge of research and development (Janssen Pharmaceutica Laboratories), marketing and sales (Virbac Laboratories) and strategy (Merial Laboratories). Thereafter he turned to finance as associate director of a venture capital company (Sudinnova), then as founder and general manager of a VC company committed to funding high-tech/biotech companies (Sud-Partners) which he sold to the Siparex group. He then devoted himself to Traditional Chinese Medicine (acupuncture, shiatsu, phytotherapy) in which he graduated while giving art song recitals in private or public concerts. Recently, he founded a holding company (Ago Pharma) whose objective is to build an industrial group dedicated to natural medicine.